Park CK - Search Results

1

Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.

Wang K, Lim HY, Shi S, Lee J, Deng S, Xie T, Zhu Z, Wang Y, Pocalyko D, Yang WJ, Rejto PA, Mao M, Park CK, Xu J. Wang K, et al. Among authors: park ck. Hepatology. 2013 Aug;58(2):706-17. doi: 10.1002/hep.26402. Epub 2013 Jul 1. Hepatology. 2013. PMID: 23505090

2

PIK3CA mutations in hepatocellular carcinoma in Korea.

Kim H, Park CK, Lee SJ, Rha SY, Park KH, Lim HY. Kim H, et al. Among authors: park kh, park ck. Yonsei Med J. 2013 Jul;54(4):883-7. doi: 10.3349/ymj.2013.54.4.883. Yonsei Med J. 2013. PMID: 23709421 Free PMC article.

3

Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.

Lim HY, Sohn I, Deng S, Lee J, Jung SH, Mao M, Xu J, Wang K, Shi S, Joh JW, Choi YL, Park CK. Lim HY, et al. Among authors: park ck. Ann Surg Oncol. 2013 Nov;20(12):3747-53. doi: 10.1245/s10434-013-3070-y. Epub 2013 Jun 26. Ann Surg Oncol. 2013. PMID: 23800896

4

A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.

Lee SJ, Lee J, Sohn I, Mao M, Kai W, Park CK, Lim HY. Lee SJ, et al. Among authors: park ck. Anticancer Res. 2013 Nov;33(11):5179-86. Anticancer Res. 2013. PMID: 24222167

5

Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas.

Ouyang L, Lee J, Park CK, Mao M, Shi Y, Gong Z, Zheng H, Li Y, Zhao Y, Wang G, Fu H, Kim J, Lim HY. Ouyang L, et al. Among authors: park ck. BMC Med Genomics. 2014 Jan 9;7:2. doi: 10.1186/1755-8794-7-2. BMC Med Genomics. 2014. PMID: 24405831 Free PMC article.

6

Loss of Tuberous Sclerosis Complex 2 (TSC2) as a Predictive Biomarker of Response to mTOR Inhibitor Treatment in Patients with Hepatocellular Carcinoma.

Cho J, Lee J, Kim J, Kim ST, Lee S, Kim SY, Ha SY, Park CK, Lim HY. Cho J, et al. Among authors: park ck. Transl Oncol. 2016 Oct;9(5):466-471. doi: 10.1016/j.tranon.2016.08.009. Transl Oncol. 2016. PMID: 27751352 Free PMC article.

7

An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients.

Lee JY, Hong M, Lee J, Lee S, Kim KM, Park C, Lim HY. Lee JY, et al. J Cancer. 2017 Feb 25;8(5):730-736. doi: 10.7150/jca.17887. eCollection 2017. J Cancer. 2017. PMID: 28382134 Free PMC article.

8

Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma.

Ha SY, Yu JI, Choi C, Kang SY, Joh JW, Paik SW, Kim S, Kim M, Park HC, Park CK. Ha SY, et al. Among authors: park hc, park ck. Sci Rep. 2019 Oct 14;9(1):14738. doi: 10.1038/s41598-019-50594-2. Sci Rep. 2019. PMID: 31611609 Free PMC article.

9

Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.

Kim TM, Yim SH, Shin SH, Xu HD, Jung YC, Park CK, Choi JY, Park WS, Kwon MS, Fiegler H, Carter NP, Rhyu MG, Chung YJ. Kim TM, et al. Among authors: park ws, park ck. Int J Cancer. 2008 Dec 15;123(12):2808-15. doi: 10.1002/ijc.23901. Int J Cancer. 2008. PMID: 18803288 Free PMC article.

10

Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute.

Shin Y, Ha SY, Hyeon J, Lee B, Lee J, Jang KT, Kim KM, Park YS, Park CK. Shin Y, et al. Among authors: park ys, park ck. Cancer Res Treat. 2015 Oct;47(4):738-46. doi: 10.4143/crt.2014.224. Epub 2015 Feb 16. Cancer Res Treat. 2015. PMID: 25687852 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,926 results

Search Page

Filters